Interestingly, neither AKT inhibitors nor EGFR‐TKI induce significant cell death by themselves, but in combination they are highly potent at inducing apoptosis, suggesting that their combined effects have lethal consequences for tumor cells. This evidence concerns the gene AKT1 and neoplasm.